Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509795
Status:
COMPLETED
Last Update Posted:
2012-12-28
First Post:
2007-07-31
Brief Title:
Vascular Endothelial Growth Factor VEGF Trap-EyeInvestigation of Efficacy and Safety in Wet Age-Related Macular DegenerationAMD
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Study Overview
Official Title:
A Randomized Double Masked Active Controlled Phase III Study of the Efficacy Safety and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-Related Macular Degeneration
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIEW1
Brief Summary:
This study is a phase 3 double-masked randomized study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration Approximately 1200 patients will be randomized in the US and Canada
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None